Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Rhabdoviruses as vaccine platforms for infectious disease and cancer
Franz Zemp1,2, Jahanara Rajwani1,2,3, Douglas J Mahoney1,2,4,3
1a Alberta Children's Hospital Research Institute , Calgary , Canada.
Abstract:
The family Rhabdoviridae (RV) comprises a large, genetically diverse collection of single-stranded, negative sense RNA viruses from the order Mononegavirales. Several RV members are being developed as live-attenuated vaccine vectors for the prevention or treatment of infectious disease and cancer. These include the prototype recombinant Vesicular Stomatitis Virus (rVSV) and the more recently developed recombinant Maraba Virus, both species within the genus Vesiculoviridae. A relatively strong safety profile in humans, robust immunogenicity and genetic malleability are key features that make the RV family attractive vaccine platforms. Currently, the rVSV vector is in preclinical development for vaccination against numerous high-priority infectious diseases, with clinical evaluation underway for HIV/AIDS and Ebola virus disease. Indeed, the success of the rVSV-ZEBOV vaccine during the 2014-15 Ebola virus outbreak in West Africa highlights the therapeutic potential of rVSV as a vaccine vector for acute, life-threatening viral illnesses. The rVSV and rMaraba platforms are also being tested as 'oncolytic' cancer vaccines in a series of phase 1-2 clinical trials, after being proven effective at eliciting immune-mediated tumour regression in preclinical mouse models. In this review, we discuss the biological and genetic features that make RVs attractive vaccine platforms and the development and ongoing testing of rVSV and rMaraba strains as vaccine vectors for infectious disease and cancer.
Insights
Rhabdoviridae viruses, like recombinant Vesicular Stomatitis Virus (rVSV), show promise as vaccine vectors. Their safety and genetic adaptability make them suitable for developing vaccines against infectious diseases and cancer.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- The Rhabdoviridae family comprises diverse RNA viruses.
- Several Rhabdoviridae members are explored as live-attenuated vaccine vectors.
- Recombinant Vesicular Stomatitis Virus (rVSV) and recombinant Maraba Virus are key examples.
Purpose of the Study:
- To review the biological and genetic features of Rhabdoviridae that make them attractive vaccine platforms.
- To discuss the development and testing of rVSV and rMaraba strains as vaccine vectors.
Main Methods:
- Review of existing literature on Rhabdoviridae as vaccine vectors.
- Discussion of preclinical and clinical trial data for rVSV and rMaraba platforms.
- Analysis of safety, immunogenicity, and genetic malleability of these viral vectors.
Main Results:
- Rhabdoviridae possess favorable safety profiles, strong immunogenicity, and genetic flexibility for vaccine development.
- rVSV is under preclinical development for various infectious diseases and in clinical trials for HIV/AIDS and Ebola.
- The rVSV-ZEBOV vaccine demonstrated success during the Ebola outbreak, highlighting its potential.
- rVSV and rMaraba platforms are being investigated as oncolytic cancer vaccines in clinical trials.
Conclusions:
- Rhabdoviridae, particularly rVSV and rMaraba, are highly promising vaccine platforms.
- These vectors offer potential for both infectious disease prevention and cancer immunotherapy.
- Ongoing research continues to validate their therapeutic applications.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Cancer
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

